TWST
Twist Bioscience Corp
$69.22
-6.37%
$4.6B
No data for this timeframe.
Vol
Market Cap$4.6B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (93%)
Inst. Holders6 funds
Inst. Value$245.3M
Inst. Activity1 buys / 3 sells
Insider Activity0B / 36S
Insider Net $-$9.3M
Reddit Sentiment70° Bullish
SEC Reports11
Exchange Nasdaq·Sector Biological Products, (No Diagnostic Substances)·Inc. DE·CIK 0001581280·Prev Close $73.93
Recent Activity
Jun 5, 2026
short_volume
Short Volume: TWST — 56.8% short (0.6M / 1.0M)
Short: 583,794 | Exempt: 547 | TRF Vol: 1,026,996 | Short Ratio: 56.8% | Off-exchange volume (dark p
Jun 2, 2026
SEC
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (vi
CLUSTER — Impact 3/10
Jun 1, 2026
SEC
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-m
CLUSTER — Impact 3/10
May 29, 2026
Insider
Cho Dennis sold 14,205 shares
See Remarks @ $69.75 ($990.8K)
May 29, 2026
Insider
Laponis Adam sold 4,000 shares
Chief Financial Officer @ $70.00 ($280.0K)
May 28, 2026
SEC
A substantial insider selling cluster at Twist Bioscience, concentrated on May 21-26, 2026, with CEO Emily Leproust alon
CLUSTER — Impact 5/10
May 28, 2026
Insider
Starovasnik Melissa A. sold 2,500 shares
Director @ $68.00 ($170.0K)
Inst.
MORGAN STANLEY — TRIM
866,356 shares ($27.5M)
Price Targets
$64.38
-7.0% upside
Sell
Current $69.22
Low $36.00
Median $65.50
High $80.00
8 analysts
$36.00
$80.00
Analyst Ratings
8Strong Buy
6Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 5, 2026 | Leerink Partners | UPGRADE | Market Perform → Outperform |
| May 5, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy → Buy |
| May 5, 2026 | Baird | MAINTAIN | Outperform → Outperform |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight → Overweight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Next FY | $-2.05 ▼ -8.8% | $-2.05 — $-2.05 | 1 | |
| Current FY | $-1.99 ▼ -19.6% | $-2.17 — $-1.54 | -53% YoY | 8 |
| Next Q | $-0.36 ▼ -12.1% | $-0.43 — $-0.25 | 19% YoY | 7 |
| Current Q | $-0.47 ▼ -17.6% | $-0.52 — $-0.37 | -243% YoY | 7 |
Latest Reports
NEUTRAL
CLUSTER
3/10
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, including the CEO (vi
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who sold ~$3.2M in open-m
Jun 1, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $183.2M | — |
| MORGAN STANLEY | $27.5M | TRIM |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $17.4M | NEW |
| BANK OF AMERICA CORP | $12.7M | TRIM |
| WELLS FARGO & COMPANY/MN | $2.4M | ADD |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 29, 2026 | Cho Dennis | SELL | $990.8K |
| May 29, 2026 | Laponis Adam | SELL | $280.0K |
| May 28, 2026 | Starovasnik Melissa | SELL | $170.0K |
| May 28, 2026 | Leproust Emily | M | $0.00 |
| May 28, 2026 | Leproust Emily | SELL | $96.8K |
Reddit Sentiment
70°
Bullish
Bearish
Neutral
Bullish
6 institutional holders with $245.3M total value (7,734,056 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net selling activity: 3 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 5,776,198 | $183.2M | 74.7% | — |
| 2 | MORGAN STANLEY | 866,356 | $27.5M | 11.2% | TRIM -41.9% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 548,392 | $17.4M | 7.1% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 399,354 | $12.7M | 5.2% | TRIM -34.6% |
| 5 | WELLS FARGO & COMPANY/MN | 74,819 | $2.4M | 1.0% | ADD +60.0% |
| 6 | FMR LLC | 68,937 | $2.2M | 0.9% | TRIM -68.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | TRIM | 1,492,106 | 866,356 | -41.9% | $27.5M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 46,760 | 74,819 | +60.0% | $2.4M | 2025-Q4 |
| FMR LLC | TRIM | 219,532 | 68,937 | -68.6% | $2.2M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | EXIT | 73,755 | 0 | -100.0% | $0.00 | 2025-Q4 |
| UBS Group AG | DOUBLED | 216,597 | 514,928 | +137.7% | $14.5M | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 688,332 | 450,374 | -34.6% | $12.7M | 2025-Q3 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 115,955 | 73,755 | -36.4% | $2.1M | 2025-Q3 |
| NORGES BANK | EXIT | 20,043 | 0 | -100.0% | $0.00 | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 13,800 | 0 | -100.0% | $0.00 | 2025-Q3 |
| MORGAN STANLEY | ADD | 610,742 | 1,200,446 | +96.6% | $44.2M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 282,772 | 688,332 | +143.4% | $25.3M | 2025-Q2 |
| NORGES BANK | NEW | — | 20,043 | — | $737.4K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 193,908 | 13,800 | -92.9% | $507.7K | 2025-Q2 |
| MORGAN STANLEY | TRIM | 899,169 | 610,742 | -32.1% | $24.0M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 398,708 | 193,908 | -51.4% | $7.6M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 347,532 | 140,676 | -59.5% | $5.5M | 2025-Q1 |
| NORGES BANK | EXIT | 163,210 | 0 | -100.0% | $0.00 | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 214,310 | 398,708 | +86.0% | $18.5M | 2024-Q4 |
| UBS Group AG | ADD | 150,289 | 227,636 | +51.5% | $10.6M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 28,164 | 37,886 | +34.5% | $1.8M | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 524,942 | — | $23.7M | 2024-Q3 |
9 unique insiders with 36 transactions. Net insider value: -$9.3M ($0.00 bought, $9.3M sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 29, 2026 | Cho Dennis | See Remarks | SELL | 14,205 | $69.75 | $990.8K |
| May 29, 2026 | Laponis Adam | Chief Financial Officer | SELL | 4,000 | $70.00 | $280.0K |
| May 28, 2026 | Starovasnik Melissa A. | Director | SELL | 2,500 | $68.00 | $170.0K |
| May 28, 2026 | Leproust Emily M. | Chief Executive Officer | M | 16,470 | $0.00 | $0.00 |
| May 28, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,482 | $65.33 | $96.8K |
| May 28, 2026 | Leproust Emily M. | Chief Executive Officer | M | 16,470 | $8.82 | $145.3K |
| May 27, 2026 | Leproust Emily M. | Chief Executive Officer | M | 25,017 | $8.82 | $220.6K |
| May 27, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 23,752 | $65.24 | $1.5M |
| May 27, 2026 | Leproust Emily M. | Chief Executive Officer | M | 25,017 | $0.00 | $0.00 |
| May 26, 2026 | Starovasnik Melissa A. | Director | SELL | 500 | $61.04 | $30.5K |
| May 26, 2026 | Leproust Emily M. | Chief Executive Officer | M | 24,282 | $8.82 | $214.2K |
| May 26, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 24,282 | $65.08 | $1.6M |
| May 26, 2026 | Leproust Emily M. | Chief Executive Officer | M | 24,282 | $0.00 | $0.00 |
| May 26, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 800 | $62.48 | $50.0K |
| May 21, 2026 | Green Paula | SVP of Human Resources | SELL | 1,399 | $53.26 | $74.5K |
| May 21, 2026 | Finn Patrick John | President and COO | SELL | 4,160 | $53.26 | $221.5K |
| May 21, 2026 | Cho Dennis | See Remarks | SELL | 1,642 | $53.26 | $87.4K |
| May 21, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 688 | $53.26 | $36.6K |
| May 21, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 6,888 | $53.26 | $366.8K |
| May 21, 2026 | Laponis Adam | Chief Financial Officer | SELL | 2,019 | $53.26 | $107.5K |
| May 12, 2026 | JOHANNESSEN JAN | Director | M | 12,000 | $14.00 | $168.0K |
| May 12, 2026 | JOHANNESSEN JAN | Director | SELL | 12,000 | $56.12 | $673.4K |
| May 12, 2026 | JOHANNESSEN JAN | Director | M | 12,000 | $0.00 | $0.00 |
| May 8, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 4,961 | $56.88 | $282.2K |
| May 4, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 164 | $57.15 | $9.4K |
| May 4, 2026 | Cho Dennis | See Remarks | SELL | 1,962 | $57.15 | $112.1K |
| May 4, 2026 | Finn Patrick John | President and COO | SELL | 2,844 | $57.15 | $162.5K |
| May 4, 2026 | Green Paula | SVP of Human Resources | SELL | 1,116 | $57.15 | $63.8K |
| May 4, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 5,127 | $57.15 | $293.0K |
| Apr 23, 2026 | Finn Patrick John | President and COO | SELL | 2,321 | $60.76 | $141.0K |
| Apr 22, 2026 | Leproust Emily M. | Chief Executive Officer | M | 8,061 | $8.82 | $71.1K |
| Apr 22, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 7,910 | $65.28 | $516.3K |
| Apr 22, 2026 | Leproust Emily M. | Chief Executive Officer | M | 8,061 | $0.00 | $0.00 |
| Apr 21, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,610 | $65.01 | $104.7K |
| Apr 21, 2026 | Leproust Emily M. | Chief Executive Officer | M | 1,610 | $8.82 | $14.2K |
| Apr 21, 2026 | Leproust Emily M. | Chief Executive Officer | M | 1,610 | $0.00 | $0.00 |
| Apr 17, 2026 | Laponis Adam | Chief Financial Officer | SELL | 4,000 | $60.00 | $240.0K |
| Apr 14, 2026 | Laponis Adam | Chief Financial Officer | SELL | 3,000 | $55.00 | $165.0K |
| Apr 9, 2026 | Laponis Adam | Chief Financial Officer | SELL | 2,597 | $49.89 | $129.6K |
| Apr 1, 2026 | Starovasnik Melissa A. | Director | SELL | 1,000 | $51.00 | $51.0K |
| Mar 20, 2026 | Green Paula | SVP of Human Resources | SELL | 297 | $43.79 | $13.0K |
| Mar 20, 2026 | Cho Dennis | See Remarks | SELL | 354 | $43.79 | $15.5K |
| Mar 20, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 1,742 | $43.79 | $76.3K |
| Mar 17, 2026 | CHESS ROBERT | Director | M | 10,000 | $11.89 | $118.9K |
| Mar 17, 2026 | CHESS ROBERT | Director | SELL | 10,000 | $47.00 | $470.0K |
| Mar 17, 2026 | CHESS ROBERT | Director | M | 10,000 | $0.00 | $0.00 |
| Mar 6, 2026 | WERNER ROBERT F. | Chief Accounting Officer | SELL | 246 | $46.43 | $11.4K |
| Mar 6, 2026 | Cho Dennis | See Remarks | SELL | 425 | $46.43 | $19.7K |
| Mar 6, 2026 | Green Paula | SVP of Human Resources | SELL | 935 | $46.43 | $43.4K |
| Mar 6, 2026 | Leproust Emily M. | Chief Executive Officer | SELL | 2,423 | $46.43 | $112.5K |
11 SEC filing reports analyzed. Sentiment: 1 bullish, 5 bearish, 0 mixed, 5 neutral. Avg impact: 4.7/10.
NEUTRAL
CLUSTER
3/10
Four insiders at Twist Bioscience sold a total of $1.31M in open-market sales over a 7-day window, i
Jun 2, 2026
NEUTRAL
CLUSTER
3/10
A cluster of insider selling at Twist Bioscience over the past week, led by CEO Emily Leproust who s
Jun 1, 2026
BEARISH
CLUSTER
5/10
A substantial insider selling cluster at Twist Bioscience, concentrated on May 21-26, 2026, with CEO
May 28, 2026
NEUTRAL
CLUSTER
3/10
Six TWST insiders—including the CEO, CFO, and COO—collectively sold 16,796 shares for ~$807K on May
May 26, 2026
BULLISH
8-K
7/10
Twist Bioscience reported fiscal Q2 2026 revenue of $110.7M, a 19% YoY increase and above the prior
May 4, 2026
NEUTRAL
CLUSTER
4/10
Twist Bioscience CEO Emily Leproust and CFO Adam Laponis sold a combined $345K in shares over the pa
Apr 23, 2026
NEUTRAL
CLUSTER
3/10
Three insiders at Twist Bioscience sold shares in a coordinated open-market transaction on March 20,
Mar 24, 2026
BEARISH
CLUSTER
5/10
Three insiders at Twist Bioscience sold shares in a coordinated 7-day window, including CEO Emily Le
Mar 10, 2026
BEARISH
CLUSTER
6/10
Six insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and other executives, sold share
Feb 26, 2026
BEARISH
CLUSTER
7/10
Four corporate insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and another executive
Feb 26, 2026
BEARISH
CLUSTER
6/10
Three insiders at Twist Bioscience Corp sold shares in a coordinated open-market transaction on Febr
Feb 25, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (93% buy). Based on 15 analysts: 8 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$64.38 mean target
-7.0% upside
Sell (1.33)
$36.00 Low
$80.00 High
| Metric | Value |
|---|---|
| Current Price | $69.22 |
| Target Low | $36.00 |
| Target Mean | $64.38 |
| Target Median | $65.50 |
| Target High | $80.00 |
| # Analysts | 8 |
| Recommendation | Sell (1.33) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next FY 2027-09-30 |
$-2.05 | $-2.05 | $-2.05 | — | -8.8% | — | $0.5B | 15.6% | 1 |
| Current FY 2026-09-30 |
$-1.99 | $-2.17 | $-1.54 | -53.1% | -19.6% | 0↑ 7↓ | $0.4B | 18.6% | 8 |
| Next Q 2026-09-30 |
$-0.36 | $-0.43 | $-0.25 | 19.1% | -12.1% | 2↑ 4↓ | $0.1B | 18.7% | 7 |
| Current Q 2026-06-30 |
$-0.47 | $-0.52 | $-0.37 | -243.1% | -17.6% | 0↑ 5↓ | $0.1B | 19.3% | 7 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.472 | |
| 7d ago | $-0.431 | -0.042 |
| 30d ago | $-0.402 | -0.071 |
| 60d ago | $-0.399 | -0.073 |
| 90d ago | $-0.393 | -0.079 |
12 analyst firms have rated this stock: 2 upgrades, 0 downgrades, 4 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 5, 2026 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| May 5, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| May 5, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| May 5, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 14, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Mar 30, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Feb 3, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Feb 3, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 26, 2026 | Guggenheim | MAINTAIN | Buy | Buy |
| Jan 8, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| Dec 15, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Nov 17, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Nov 4, 2025 | Stephens & Co. | INITIATE | — | Overweight |
| Oct 7, 2025 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Oct 2, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| May 6, 2025 | Goldman Sachs | MAINTAIN | Buy | Buy |
| May 6, 2025 | Guggenheim | REITERATE | Buy | Buy |
| May 6, 2025 | Baird | MAINTAIN | Outperform | Outperform |
| May 6, 2025 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Apr 10, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Feb 4, 2025 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| Feb 4, 2025 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Feb 4, 2025 | Baird | MAINTAIN | Outperform | Outperform |
| Dec 13, 2024 | Wolfe Research | INITIATE | — | Outperform |
| Nov 26, 2024 | TD Cowen | REITERATE | Buy | Buy |
| Nov 19, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| Nov 19, 2024 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| Nov 19, 2024 | Baird | MAINTAIN | Outperform | Outperform |
| Oct 17, 2024 | Leerink Partners | MAINTAIN | Market Perform | Market Perform |
| Oct 1, 2024 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Aug 5, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| Aug 5, 2024 | JP Morgan | MAINTAIN | Underweight | Underweight |
| Aug 5, 2024 | Baird | MAINTAIN | Outperform | Outperform |
| Jul 9, 2024 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Jun 28, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| Jun 13, 2024 | TD Cowen | MAINTAIN | Buy | Buy |
| Jun 5, 2024 | Guggenheim | INITIATE | — | Buy |
| May 6, 2024 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| May 3, 2024 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| May 3, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| May 3, 2024 | Baird | MAINTAIN | Outperform | Outperform |
| Apr 10, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| Feb 5, 2024 | Scotiabank | MAINTAIN | Sector Outperform | Sector Outperform |
| Jan 25, 2024 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 18, 2024 | Goldman Sachs | MAINTAIN | Buy | Buy |
| Jan 17, 2024 | Goldman Sachs | UPGRADE | Neutral | Buy |
| Sep 27, 2023 | Berenberg | INITIATE | — | Buy |
| Aug 7, 2023 | Barclays | MAINTAIN | Overweight | Overweight |
| Jul 13, 2023 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 6 | 1 | 0 | 0 | 93% | |
| May 1, 2026 | 7 | 7 | 2 | 0 | 0 | 88% | |
| Apr 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Mar 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Feb 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Jan 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
70°
Bullish
Bearish
Neutral
Bullish
6 mentions
4 bullish
0 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Apr 24, 2026 | 3 | 64° Warm | 2 | 0 | 3 |
| Apr 24, 2026 | 3 | 64° Warm | 2 | 0 | 3 |
Recent Reddit Threads
TWST bull run coming. INVEST
▲ 1
💬 1
⚡ 0.5
TWST ticker symbol. INVEST
▲ 1
💬 1
⚡ 0.5
TWST , BIOSCIENCE BULLISH
▲ 1
💬 0
⚡ 0.5
Jun 5, 2026
short_volume
Short Volume: TWST — 56.8% short (0.6M / 1.0M)
Short: 583,794 | Exempt: 547 | TRF Vol: 1,026,996 | Short Ratio: 56.8% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: TWST — 57.0% short (0.3M / 0.5M)
Short: 299,805 | Exempt: 8,115 | TRF Vol: 525,783 | Short Ratio: 57.0% | Off-exchange volume (dark pool + OTC)
May 29, 2026
short_volume
Short Volume: TWST — 57.7% short (0.4M / 0.7M)
Short: 397,370 | Exempt: 19 | TRF Vol: 689,144 | Short Ratio: 57.7% | Off-exchange volume (dark pool + OTC)
May 26, 2026
short_volume
Short Volume: TWST — 59.1% short (0.4M / 0.6M)
Short: 363,726 | Exempt: 0 | TRF Vol: 615,112 | Short Ratio: 59.1% | Off-exchange volume (dark pool + OTC)
May 21, 2026
short_volume
Short Volume: TWST — 58.4% short (0.4M / 0.7M)
Short: 391,646 | Exempt: 0 | TRF Vol: 670,972 | Short Ratio: 58.4% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: TWST — 55.0% short (0.3M / 0.6M)
Short: 310,384 | Exempt: 7 | TRF Vol: 564,094 | Short Ratio: 55.0% | Off-exchange volume (dark pool + OTC)
May 4, 2026
earnings_calendar
TWST Q2 2026 Earnings Scheduled — 2026-05-04
Apr 21, 2026
short_volume
Short Volume: TWST — 69.8% short (0.5M / 0.8M)
Short: 545,933 | Exempt: 274 | TRF Vol: 782,047 | Short Ratio: 69.8% | Off-exchange volume (dark pool + OTC)
Apr 15, 2026
short_volume
Short Volume: TWST — 55.0% short (0.3M / 0.5M)
Short: 286,670 | Exempt: 129 | TRF Vol: 520,969 | Short Ratio: 55.0% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_interest
FTD: TWST — 19,702 shares ($1.0M) failed to deliver
Settlement: 20260406, Price: $50.21, FTD Value: $989,237.42, TWIST BIOSCIENCE CORP COM (DE)
Mar 23, 2026
short_volume
Short Volume: TWST — 70.1% short (0.4M / 0.5M)
Short: 350,956 | Exempt: 0 | TRF Vol: 500,661 | Short Ratio: 70.1% | Off-exchange volume (dark pool + OTC)
Mar 18, 2026
short_interest
FTD: TWST — 15,212 shares ($0.7M) failed to deliver
Settlement: 20260318, Price: $47.28, FTD Value: $719,223.36, TWIST BIOSCIENCE CORP COM (DE)
Mar 11, 2026
short_interest
FTD: TWST — 11,626 shares ($0.5M) failed to deliver
Settlement: 20260311, Price: $45.40, FTD Value: $527,820.4, TWIST BIOSCIENCE CORP COM (DE)
Feb 23, 2026
short_interest
FTD: TWST — 371,330 shares ($18.0M) failed to deliver
Settlement: 20260223, Price: $48.59, FTD Value: $18,042,924.7, TWIST BIOSCIENCE CORP COM (DE)
Feb 11, 2026
short_interest
FTD: TWST — 29,526 shares ($1.4M) failed to deliver
Settlement: 20260211, Price: $49.06, FTD Value: $1,448,545.56, TWIST BIOSCIENCE CORP COM (DE)